Is Cadrenal Therapeutics, Inc. Common Stock (CVKD) a Buy, Sell, or Hold?
Cadrenal Therapeutics, Inc. Common Stock
NASDAQ:CVKD
$2.42 USD
$0 (0.0%)
- Volume
- 49.43K
- Average Volume
- 73.33K
- Market Capitalization
- $7.45M
- P/E Ratio
- -0.43
- Dividend Yield
- 0.00%
- Price Target
- $32.00
- Year High
- $14.64
- Year Low
- $2.29
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.68
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
10
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
45
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 295.68K
CVKD Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CVKD Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Pham Quang X | director, 10 percent owner, officer: Chairman and CEO | 2026-06-29 | S-Sale | 3.03 | 2026-07-01 |
| Pham Quang X | director, 10 percent owner, officer: Chairman, CEO and Interim CFO | 2026-06-25 | S-Sale | 3 | 2026-06-26 |
| Pham Quang X | director, 10 percent owner, officer: Chairman, CEO and Interim CFO | 2026-06-26 | S-Sale | 3.05 | 2026-06-26 |
| Pham Quang X | director, 10 percent owner, officer: Chairman, CEO and Interim CFO | 2026-06-22 | S-Sale | 3.55 | 2026-06-24 |
| Pham Quang X | director, 10 percent owner, officer: Chairman, CEO and Interim CFO | 2026-06-23 | S-Sale | 3.2 | 2026-06-24 |
| Pham Quang X | director, 10 percent owner, officer: Chairman, CEO and Interim CFO | 2026-06-16 | S-Sale | 3.18 | 2026-06-18 |
| Pham Quang X | director, 10 percent owner, officer: Chairman, CEO and Interim CFO | 2026-06-17 | S-Sale | 3.16 | 2026-06-18 |
| Pham Quang X | director, 10 percent owner, officer: Chairman, CEO and Interim CFO | 2026-06-11 | S-Sale | 4.12 | 2026-06-15 |
| Pham Quang X | director, 10 percent owner, officer: Chairman, CEO and Interim CFO | 2026-06-12 | S-Sale | 3.94 | 2026-06-15 |
| Pham Quang X | director, 10 percent owner, officer: Chairman, CEO and Interim CFO | 2026-06-15 | S-Sale | 3.58 | 2026-06-15 |
| Pham Quang X | director, 10 percent owner, officer: Chairman, CEO and Interim CFO | 2026-06-08 | S-Sale | 4.38 | 2026-06-10 |
| Pham Quang X | director, 10 percent owner, officer: Chairman, CEO and Interim CFO | 2026-06-09 | S-Sale | 4.06 | 2026-06-10 |
| Pham Quang X | director, 10 percent owner, officer: Chairman, CEO and Interim CFO | 2026-06-10 | S-Sale | 4.21 | 2026-06-10 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2026-06-03 | S-Sale | 4.26 | 2026-06-05 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2026-06-04 | S-Sale | 4.41 | 2026-06-05 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2026-06-05 | S-Sale | 4.42 | 2026-06-05 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2026-05-29 | S-Sale | 5.01 | 2026-06-02 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2026-06-02 | S-Sale | 4.46 | 2026-06-02 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2026-05-11 | S-Sale | 5.76 | 2026-05-29 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2026-05-12 | S-Sale | 5.28 | 2026-05-29 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2026-05-28 | S-Sale | 4.93 | 2026-05-29 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2026-05-22 | S-Sale | 5.69 | 2026-05-26 |
| Szot Matthew K | officer: Chief Financial Officer | 2025-12-29 | S-Sale | 6.97 | 2025-12-31 |
| Golden Lee Scott | director | 2025-12-02 | A-Award | 8.27 | 2025-12-03 |
| Golden Lee Scott | director | 2025-11-24 | 0 | 2025-12-03 | |
| Szot Matthew K | officer: Chief Financial Officer | 2025-10-24 | S-Sale | 13.99 | 2025-10-28 |
| Szot Matthew K | officer: Chief Financial Officer | 2025-10-27 | S-Sale | 13.99 | 2025-10-28 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2025-10-24 | S-Sale | 14.03 | 2025-10-28 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2025-10-27 | S-Sale | 13.99 | 2025-10-28 |
| Szot Matthew K | officer: Chief Financial Officer | 2025-10-09 | S-Sale | 13.99 | 2025-10-14 |
| Szot Matthew K | officer: Chief Financial Officer | 2025-10-13 | S-Sale | 14.07 | 2025-10-14 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2025-10-09 | S-Sale | 14.02 | 2025-10-14 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2025-10-13 | S-Sale | 14.15 | 2025-10-14 |
| Szot Matthew K | officer: Chief Financial Officer | 2025-10-06 | S-Sale | 13.99 | 2025-10-07 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2025-10-02 | S-Sale | 14.13 | 2025-10-03 |
| Szot Matthew K | officer: Chief Financial Officer | 2025-09-29 | S-Sale | 14 | 2025-10-01 |
| Szot Matthew K | officer: Chief Financial Officer | 2025-10-01 | S-Sale | 13.99 | 2025-10-01 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2025-09-29 | S-Sale | 14.01 | 2025-10-01 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2025-10-01 | S-Sale | 14.01 | 2025-10-01 |
| Szot Matthew K | officer: Chief Financial Officer | 2025-09-24 | S-Sale | 13.9953 | 2025-09-26 |
| Szot Matthew K | officer: Chief Financial Officer | 2025-09-25 | S-Sale | 14.0534 | 2025-09-26 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2025-09-24 | S-Sale | 13.99 | 2025-09-26 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2025-09-25 | S-Sale | 14.09 | 2025-09-26 |
| Szot Matthew K | officer: Chief Financial Officer | 2025-08-27 | S-Sale | 13.995 | 2025-08-29 |
| Szot Matthew K | officer: Chief Financial Officer | 2025-08-28 | S-Sale | 14 | 2025-08-29 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2025-08-27 | S-Sale | 13.99 | 2025-08-29 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2025-08-28 | S-Sale | 13.99 | 2025-08-29 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2025-01-23 | A-Award | 19.79 | 2025-03-24 |
| Ferguson James J. III | officer: Chief Medical Officer | 2025-02-05 | A-Award | 19.75 | 2025-02-06 |
| Ferguson James J. III | officer | 2025-02-05 | 0 | 2025-02-06 | |
| MURPHY JOHN RAYMOND | director | 2025-01-23 | A-Award | 19.79 | 2025-01-24 |
| WILSON GLYNN | director | 2025-01-23 | A-Award | 19.79 | 2025-01-24 |
| Zelenkofske Steven | director | 2025-01-23 | A-Award | 19.79 | 2025-01-24 |
| Cole Jeffrey Scott | officer: Chief Operating Officer | 2025-01-23 | A-Award | 19.79 | 2025-01-24 |
| Szot Matthew K | officer: Chief Financial Officer | 2025-01-23 | A-Award | 19.79 | 2025-01-24 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2025-01-23 | A-Award | 21.769 | 2025-01-24 |
| Lisicki Robert | director | 2025-01-23 | A-Award | 19.79 | 2025-01-24 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2024-04-10 | G-Gift | 0 | 2024-04-10 |
| Cole Jeffrey Scott | officer: Chief Operating Officer | 2024-04-02 | A-Award | 0.62 | 2024-04-03 |
| Cole Jeffrey Scott | officer: Chief Operating Officer | 2022-08-01 | 0.64 | 2024-04-03 | |
| Cole Jeffrey Scott | officer: Chief Operating Officer | 2025-02-01 | 0.94 | 2024-04-03 | |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2023-10-23 | G-Gift | 0 | 2024-02-12 |
| Zelenkofske Steven | director | 2024-01-18 | A-Award | 0.94 | 2024-01-19 |
| MURPHY JOHN RAYMOND | director | 2024-01-18 | A-Award | 0.94 | 2024-01-19 |
| Lisicki Robert | director | 2024-01-18 | A-Award | 0.94 | 2024-01-19 |
| Pham Quang X | director, 10 percent owner, officer: Chief Executive Officer | 2024-01-18 | A-Award | 0.94 | 2024-01-19 |
| Szot Matthew K | officer: Chief Financial Officer | 2024-01-18 | A-Award | 0.94 | 2024-01-19 |
| WILSON GLYNN | director | 2024-01-18 | A-Award | 0.94 | 2024-01-19 |
| LOSORDO DOUGLAS W | officer: Chief Medical Officer | 2024-01-18 | A-Award | 0.94 | 2024-01-19 |
| MURPHY JOHN RAYMOND | director | 2023-10-05 | P-Purchase | 0.69 | 2023-10-06 |
| MURPHY JOHN RAYMOND | director | 2023-10-04 | P-Purchase | 0.7 | 2023-10-06 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2023-09-05 | P-Purchase | 0.8994 | 2023-09-06 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2023-09-05 | P-Purchase | 0.91 | 2023-09-06 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2023-09-01 | P-Purchase | 0.8433 | 2023-09-05 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2023-09-01 | P-Purchase | 0.9168 | 2023-09-05 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2023-09-01 | P-Purchase | 0.9222 | 2023-09-05 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2023-09-01 | P-Purchase | 0.9291 | 2023-09-05 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2023-09-01 | P-Purchase | 0.9318 | 2023-09-05 |
| Lisicki Robert | director | 2023-07-23 | A-Award | 1.2 | 2023-07-24 |
| Lisicki Robert | director: | 2023-07-23 | 0 | 2023-07-24 | |
| LOSORDO DOUGLAS W | officer: Chief Medical Officer | 2022-10-01 | 0.64 | 2023-03-31 | |
| MURPHY JOHN RAYMOND | director | 2023-03-16 | P-Purchase | 1.6699 | 2023-03-16 |
| Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | 2023-02-10 | A-Award | 1.94 | 2023-02-13 |
| WILSON GLYNN | director | 2023-01-24 | C-Conversion | 0 | 2023-01-24 |
| WILSON GLYNN | director | 2023-01-24 | C-Conversion | 0 | 2023-01-24 |
| Szot Matthew K | officer: Chief Financial Officer | 2023-01-24 | A-Award | 0 | 2023-01-24 |
| MURPHY JOHN RAYMOND | director | 2023-01-24 | C-Conversion | 0 | 2023-01-24 |
| MURPHY JOHN RAYMOND | director | 2023-01-24 | C-Conversion | 0 | 2023-01-24 |
| Zelenkofske Steven | director | 2023-07-11 | 0.64 | 2023-01-19 | |
| Zelenkofske Steven | director | 2023-01-19 | 0 | 2023-01-19 | |
| WILSON GLYNN | director | 2023-01-19 | 1 | 2023-01-19 | |
| Szot Matthew K | officer: Chief Financial Officer | 2023-01-19 | 0 | 2023-01-19 | |
| Pham Quang X | officer: CEO and Chairman | 2023-01-19 | 0 | 2023-01-19 | |
| Pham Quang X | officer: CEO and Chairman | 2023-01-19 | 0 | 2023-01-19 | |
| MURPHY JOHN RAYMOND | director | 2023-01-19 | 1 | 2023-01-19 | |
| MURPHY JOHN RAYMOND | director | 2023-01-19 | 0 | 2023-01-19 | |
| LOSORDO DOUGLAS W | officer: Chief Medical Officer | 2023-08-18 | 0.64 | 2023-01-19 |